Your journey
1What's a trial
4Get in touch
More info
You can access this
clinical trial
if you have
Purpura, Thrombocytopenic, Idiopathic
and you are
over 18
years old
This is a trial in the final phase before the treatment is released on the market.
Show me locations

The purpose

This study is a two phase study that aims to evaluate if low-dose Rituximab maintenance therapy may prolong the the effect of Rituximab in immune thrombocytopenia.

Provided treatments

  • Drug: Dexamethasone
  • Drug: Rituximab
Wondering what is the locations section for?
We will connect you to the doctor responsible for this trial and help you get more information.

Locations near you

Unfortunately, there are no recruiting locations near you. Please check the list with all locations below.
Tris trial is registered with FDA with number: NCT03010202. The sponsor of the trial is Ostfold Hospital Trust and it is looking for 100 volunteers for the current phase.
Official trial title:
Prolonging the Response by Low-dose Rituximab Maintenance Therapy in Immune Thrombocytopenia: a Randomized Placebo-controlled Trial - the PROLONG Trial